Most people are choosing the wrong drug without knowing it
Each month, millions reach for paracetamol to quiet menstrual pain — a choice shaped more by habit and marketing than by evidence. Clinical science has long established that ibuprofen, by interrupting the body's own pain-generating chemistry at its source, offers substantially greater relief for dysmenorrhoea than paracetamol, which addresses only the perception of pain rather than its cause. The distance between what people purchase and what actually works reflects a broader truth: conditions that disproportionately affect women have often been undertreated, under-explained, and left to the mercy of familiarity rather than understanding.
- Millions of people manage monthly menstrual pain with paracetamol — a drug that clinical evidence consistently shows is the wrong tool for the job.
- The mismatch is biochemical: prostaglandins drive menstrual cramps, ibuprofen blocks their production, while paracetamol merely dims pain signals in the brain without touching the underlying inflammation.
- A review of 80 trials across more than 5,800 women confirmed NSAIDs' clear superiority, yet supermarket data from over three million shoppers shows paracetamol still dominates purchasing — driven by familiarity and the perception of being 'gentler.'
- Timing amplifies the advantage: starting ibuprofen one to two days before bleeding begins can prevent the pain cycle from taking hold rather than chasing it after the fact.
- For the roughly one in five people who cannot use NSAIDs, alternatives exist — antispasmodics, hormonal contraceptives, and non-drug measures — but severe or worsening pain warrants professional assessment to rule out conditions like endometriosis.
Every month, millions of people reach for paracetamol to manage menstrual cramps. Most are choosing the wrong drug.
Supermarket transaction data covering more than three million shoppers shows paracetamol dominates period pain purchases — despite being substantially less effective than ibuprofen for this specific purpose. The gap between buying habits and clinical evidence points to something larger: dysmenorrhoea, a condition affecting countless people monthly, remains quietly undertreated.
The explanation lies in how the two drugs work. Menstrual pain originates in prostaglandins — hormone-like chemicals released as the uterine lining breaks down. High prostaglandin levels drive intense contractions, reduced blood flow, and the familiar cramping sensation. Ibuprofen, as an NSAID, blocks the enzymes that produce prostaglandins in the first place, addressing the root cause before the pain cascade begins. Paracetamol works differently — it dampens pain perception in the brain and spinal cord but does not inhibit prostaglandin production. Effective for headaches, it falls short for period pain.
A major review of 80 trials involving more than 5,800 women confirmed NSAIDs' clear superiority. Other NSAIDs — naproxen, mefenamic acid, aspirin — belong to the same family, though aspirin can worsen bleeding and is not recommended for those under 16. Where ibuprofen falls short, another NSAID may help; mefenamic acid, available by prescription, may also reduce heavy bleeding.
Timing is critical. Starting an NSAID one to two days before bleeding begins allows prostaglandin suppression before levels surge, preventing pain rather than pursuing it. NSAIDs do carry risks — stomach irritation, potential effects on kidneys and heart with prolonged use — and are not suitable for everyone. Those with asthma, kidney disease, or ulcer history should seek advice first.
For the roughly 18 percent who do not respond adequately to NSAIDs, alternatives include hyoscine butylbromide, which relaxes uterine muscle, and the combined oral contraceptive pill, which reduces prostaglandin production by thinning the womb lining. Heat and nerve stimulation devices offer additional non-drug relief. When pain is severe, worsening, or disrupting daily life, professional assessment is essential to exclude conditions such as endometriosis or fibroids.
Every month, millions of people reach for a painkiller to manage menstrual cramps. Most of them grab paracetamol. Most of them are choosing the wrong drug.
A study of supermarket transaction data covering more than three million shoppers revealed that paracetamol dominates the market for period pain relief—despite being substantially less effective than ibuprofen for this specific purpose. The gap between what people buy and what actually works points to a deeper problem: period pain, which affects countless people monthly, remains surprisingly undertreated.
The reason for this mismatch lies in how the two drugs work. Period pain, medically called dysmenorrhoea, originates in the body's own chemistry. During menstruation, the uterus releases hormone-like chemicals called prostaglandins as the womb lining breaks down. These chemicals trigger uterine contractions to shed the lining—a necessary process that, when prostaglandin levels run high, becomes intensely painful. The contractions tighten, blood flow to the uterus decreases, and the result is the cramping, dragging sensation many know well. Prostaglandins also contribute to nausea and other menstrual symptoms.
Ibuprofen tackles this problem at its source. As a nonsteroidal anti-inflammatory drug, or NSAID, ibuprofen blocks the enzymes responsible for producing prostaglandins in the first place. By reducing prostaglandin levels, it prevents the cascade of pain before it starts. Paracetamol works entirely differently. It does not meaningfully inhibit prostaglandin production. Instead, it works in the brain and spinal cord, dampening the perception of pain signals without addressing inflammation or the underlying cause. This is why paracetamol works reasonably well for headaches but falls short for period pain.
Clinical evidence bears this out decisively. A major review examining 80 trials involving more than 5,800 women found that NSAIDs were substantially more effective than paracetamol for menstrual cramps. Yet paracetamol remains the most purchased option in supermarkets. The likely explanation is familiarity, widespread marketing, and the perception that paracetamol is gentler—a reputation that, for this particular pain, does not translate to better results.
Other NSAIDs beyond ibuprofen can also work: naproxen, mefenamic acid, and aspirin all belong to the same drug family. Aspirin is less commonly recommended because it thins the blood and can make periods heavier; it is also not recommended for anyone under 16 due to the risk of Reye's syndrome, a rare but serious condition affecting the brain and liver. Among the other options, evidence shows no convincing differences in effectiveness or side effects, meaning that if ibuprofen does not provide adequate relief, another NSAID may. Mefenamic acid, available only by prescription, is sometimes preferred because it may also reduce heavy bleeding.
Timing matters significantly. NSAIDs work best when started one to two days before bleeding begins and continued through the first couple of days of menstruation. Starting early allows the drugs to suppress prostaglandin production before levels surge, preventing the pain cycle from developing in the first place.
NSAIDs are not without risks. They can irritate the stomach, increase the risk of ulcers or gastrointestinal bleeding, affect kidney function, and with long-term use, potentially impact heart health. People with asthma, kidney disease, heart problems, or a history of stomach ulcers should consult a healthcare provider before using them. They also interact with blood thinners, certain antidepressants, some blood pressure medications, and steroids. For the roughly 18 percent of people with dysmenorrhoea who do not respond adequately to NSAIDs, alternatives exist. Hyoscine butylbromide, an antispasmodic more commonly used for stomach cramps, relaxes smooth muscle in the uterus rather than targeting prostaglandins. It is less effective overall but can help those unable to take NSAIDs. The combined oral contraceptive pill offers another route by preventing ovulation and thinning the womb lining, reducing prostaglandin production and resulting in lighter, less painful periods—though it carries its own potential side effects. Heat applied to the abdomen, transcutaneous electrical nerve stimulation devices, and other non-drug measures can provide additional relief. When period pain becomes severe, worsening, or interferes with daily functioning, consulting a healthcare professional is essential to rule out conditions such as endometriosis or fibroids.
Notable Quotes
Period pain remains surprisingly poorly treated despite affecting millions every month— NZ Doctor analysis
The Hearth Conversation Another angle on the story
Why do you think paracetamol remains so dominant if ibuprofen is clearly better for this kind of pain?
It's not about efficacy at that point—it's about what people know and trust. Paracetamol has decades of marketing behind it, a reputation for being safe and gentle. Most people don't know the biochemistry of their own pain.
But the evidence is clear. Doesn't that eventually change behavior?
It should, but slowly. People don't read clinical reviews. They buy what their mother bought, what the pharmacy recommends, what feels familiar. The mismatch between evidence and practice is one of medicine's quiet failures.
What about the people for whom NSAIDs don't work at all?
That's the harder problem. Eighteen percent of people don't get relief from NSAIDs. For them, you're looking at antispasmodics, hormonal contraception, or combinations of approaches. There's no single answer.
And timing—that seems crucial but easy to miss.
Exactly. You have to start before the pain begins, which requires planning and foresight. Most people wait until they're already hurting, then reach for whatever is closest. By then, the prostaglandins have already surged.
So the real issue is that period pain is still treated reactively rather than strategically.
Yes. It's treated as something to endure and manage rather than something to prevent. That's a failure of both medicine and culture.